about
Nanoscale artificial antigen presenting cells for T cell immunotherapyVisceral adiposity index and risks of cardiovascular events and mortality in prevalent hemodialysis patientsNasal carriage of methicillin-resistant Staphylococcus aureus is associated with higher all-cause mortality in hemodialysis patients.Uremic pruritus, dialysis adequacy, and metabolic profiles in hemodialysis patients: a prospective 5-year cohort studyUse of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County StudyActivated human valvular interstitial cells sustain interleukin-17 production to recruit neutrophils in infective endocarditisRelationship between Fetuin A, Vascular Calcification and Fracture Risk in Dialysis Patients.Triglyceride to high-density lipoprotein cholesterol ratio predicts cardiovascular outcomes in prevalent dialysis patients.Association of Intensive Blood Pressure Control and Kidney Disease Progression in Nondiabetic Patients With Chronic Kidney Disease: A Systematic Review and Meta-analysis.Cytotoxic polyfunctionality maturation of cytomegalovirus-pp65-specific CD4 + and CD8 + T-cell responses in older adults positively correlates with response size.Sprouty-2 regulates HIV-specific T cell polyfunctionality.Restricted Use of Erythropoiesis-Stimulating Agent is Safe and Associated with Deferred Dialysis Initiation in Stage 5 Chronic Kidney Disease.HLA-Ig based artificial antigen presenting cells for efficient ex vivo expansion of human CTL.Risk factors for severe hypocalcemia after parathyroidectomy in prevalent dialysis patients with secondary hyperparathyroidism.Excessive Access Cannulation Site Bleeding Predicts Long-Term All-Cause Mortality in Chronic Hemodialysis Patients.Early initiation of immunosuppressive treatment in membranous nephropathy patients.Gas-forming splenic abscess due to Salmonella enterica serotype Enteritidis in a chronically hemodialyzed patient.CAPD-related peritonitis due to Salmonella enteritidis in a patient with SLE.Comparing long-term outcomes between early and delayed initiation of peritoneal dialysis following catheter implantation.New advances in CMV and immunosenescence.Decreased high-density lipoprotein cholesterol is associated with inflammation and insulin resistance in non-diabetic haemodialysis patients.The aggressiveness of urinary tract urothelial carcinoma increases with the severity of chronic kidney disease.Low serum fetuin A levels and incident stroke in patients with maintenance haemodialysis.Wnt pathway activation functionally reprograms human antigen-specific T cells.Effects of low- and high-flux dialyzers on oxidative stress and insulin resistance.Prognostic impact of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in nasopharyngeal carcinoma: A retrospective study of 180 Taiwanese patients.Peritonitis caused by Aspergillus sydowii in a patient undergoing continuous ambulatory peritoneal dialysis.Enrichment of Human CCR6+ Regulatory T Cells with Superior Suppressive Activity in Oral Cancer.Cognitive-behavioral therapy for sleep disturbance decreases inflammatory cytokines and oxidative stress in hemodialysis patients.Higher systemic inflammation is associated with poorer sleep quality in stable haemodialysis patients.Effects of lower versus higher phosphate diets on fibroblast growth factor-23 levels in patients with chronic kidney disease: a systematic review and meta-analysis.The relationship of p1 and lewis antigens with peritoneal dialysis-related Escherichia coli peritonitis.Increased blood loss from access cannulation site during hemodialysis is associated with anemia and arteriovenous graft use.How does cytomegalovirus factor into diseases of aging and vaccine responses, and by what mechanisms?Anti-cytomegalovirus IgG antibody titer is positively associated with advanced T cell differentiation and coronary artery disease in end-stage renal disease.Poor renal outcome of antineutrophil cytoplasmic antibody negative Pauci-immune glomerulonephritis in TaiwaneseDelirium and multiple electrolyte abnormalities associated with high dose paroxetine exposureAssociation of uraemic pruritus with inflammation and hepatitis infection in haemodialysis patientsOutcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in TaiwanAssociation of low serum fetuin A levels with poor arteriovenous access patency in patients undergoing maintenance hemodialysis
P50
Q33968408-50DFC1CC-D61A-4834-9F48-CCE95F9E8058Q34306713-0A85C7FA-B204-47FE-BA01-54F560422ACBQ34497215-D68D62A4-955E-4AFF-896C-58911BD6C332Q34937539-6BABDDC4-1895-4022-B57F-F28F1B9F3A87Q35195840-4C89D1E3-E818-4168-A7B1-9387AAF14C8FQ35609357-B6437A2E-7791-4754-9F9A-97BE6DB4224CQ36072533-86C6364F-E745-4FA4-8113-03A32CB6AEEAQ36151033-D6F05211-D313-44B2-8E97-79C20BB1F39FQ36306359-5E7B3D06-FB1C-4B59-ACDE-1B731E238EAFQ36499894-EDBE0485-83BA-4765-A56B-7651E14E275AQ37410609-FF509DD9-0100-4845-9511-95B590BA6AB3Q37685792-C283ABBC-4621-4DE8-95CF-5C459E8D2D98Q38353137-2ED2B6BB-E2B5-48BC-8851-F7E6D1D5279DQ38507985-64A9DE12-C2D3-44BA-8195-053A8E9944A6Q39010535-6C518E60-7736-4AC5-804D-ADAC30DC90A0Q40334580-55666677-8370-498C-B811-5D6FF1DE3219Q40444249-FCC7921C-989E-49D4-BCE4-D43CBB8BCA88Q40500764-495955DE-AA01-4DDB-A021-D03B18B82A22Q40723873-E1BA3580-45A8-43F8-A2B1-A3DE38181343Q42652611-0D843FCF-0F83-4B2F-87E7-CA368C7100C1Q42840203-1995E0E1-B3BC-42C2-8B02-BF059A00488AQ45956754-CF8D9749-A776-42D2-A25B-33B4C61F9916Q46138663-EE187E67-FEA1-4F22-ACC2-9AEAEA2B1EF6Q46299473-1CAC4F6C-D3C0-4A57-AF8E-4BFADDD49191Q46744886-DC334D0D-77D7-4A8B-9175-1E7B2ECC3B18Q47630575-EE4470FB-F737-4D67-9EB0-E91044EC27EFQ48116705-ED92D056-0A3A-4279-AFE8-A9FAC4A0743AQ48298006-2156A906-78D2-41AC-9D4B-B6CE85DFC30FQ48298837-6B2C4D9B-1686-41B9-9E37-F33A759DB6F8Q48427951-61EB55A9-23FD-4718-8782-565EDEBCC883Q50113557-721D67D2-2B89-43DD-9DEE-9CDEB5EC424BQ50634631-B5DABB30-4FC5-46B7-BE8E-4842E36FEE77Q54314424-884CB292-5580-4285-AF1B-B5394841BDB1Q55315794-8BB0A6A2-D6F2-47EF-99C5-0DADEB107D57Q55517769-24642853-44DE-4875-A563-63C6F1A3D849Q79136036-F4509A64-C833-46DE-98E3-D337FB128218Q80227280-FB35101C-AC2A-4A52-ADCB-E47F729C304FQ81367676-7D602700-729B-4CD8-B6C5-2A9EF002C59FQ81711637-D761F52A-EFB4-484C-BA40-6AA67435BEB0Q84964007-19153082-C238-4C6E-9F8E-E40296F6B160
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Yen-Ling Chiu
@ast
Yen-Ling Chiu
@en
Yen-Ling Chiu
@es
Yen-Ling Chiu
@nl
type
label
Yen-Ling Chiu
@ast
Yen-Ling Chiu
@en
Yen-Ling Chiu
@es
Yen-Ling Chiu
@nl
prefLabel
Yen-Ling Chiu
@ast
Yen-Ling Chiu
@en
Yen-Ling Chiu
@es
Yen-Ling Chiu
@nl
P106
P1153
36741450500
P31
P496
0000-0003-4504-5571